[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group].
Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, España. rgarcias@usal.es
Ramón
R
García-Sanz
Adrián
A
Alegre
Francisco Javier
FJ
Capote
José Mariano
JM
Hernández
Laura
L
Rosiñol
Javier de la
Jde L
Rubia
Anna
A
Sureda
Felipe de
Fd
Arriba
Joan
J
Bargay
Joaquín
J
Díaz Mediavilla
José
J
García-Laraña
Juan José
JJ
Lahuerta
María Victoria
MV
Mateos
Felipe
F
Prósper
Jesús
J
San Miguel
Joan
J
Bladé
D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications*
D004164:Diphosphonates